30 April 2021 in Proceedings of the National Academy of Sciences
Spinal muscular atrophy (SMA) is a motoneuron disease caused by deletions of the Survival of Motoneuron 1 gene (SMN1) and low SMN protein levels. SMN restoration is the concept behind a number of recently approved drugs which result in impressive yet limited effects. Since SMN has already been enhanced in treated patients, complementary SMN-independent approaches are needed. Previously, a number of altered signaling pathways which regulate motoneuron degeneration have been identified as candidate targets. However, signaling pathways form networks, and their connectivity is still unknown in SMA. Here, we used presymptomatic SMA mice to elucidate the network of altered signaling in SMA. The SMA network is structured in two clusters with AKT and 14-3-3 ζ/δ in their centers. Both clusters are connected by B-Raf as a major signaling hub. The direct interaction of B-Raf with 14-3-3 ζ/δ is important for an efficient neurotrophic activation of the MEK/ERK pathway and crucial for motoneuron survival. Further analyses in SMA mice revealed that both proteins were down-regulated in motoneurons and the spinal cord with B-Raf being reduced at presymptomatic stages. Primary fibroblasts and iPSC-derived motoneurons from SMA patients both showed the same pattern of down-regulation. This mechanism is conserved across species since a Caenorhabditis elegans SMA model showed less expression of the B-Raf homolog lin-45. Accordingly, motoneuron survival was rescued by a cell autonomous lin-45 expression in a C. elegans SMA model resulting in improved motor functions. This rescue was effective even after the onset of motoneuron degeneration and mediated by the MEK/ERK pathway. Significance The mechanisms of neurodegeneration are important targets for future treatments of the devastating motoneuron disease spinal muscular atrophy (SMA). Here, we show an altered signaling network in SMA models and patient cells with a reduced B-Raf expression in the network center. B-Raf is crucial for motoneuron survival, and we present data that B-Raf restoration ameliorates motoneuron loss and symptoms in SMA models.
11 December 2025 in ACS Omega
MCMaria Rachele Ceccarini
+11
Flavonoid-rich Lotus species are promising sustainable sources of bioactive phytochemicals due to their adaptability, high biomass production, and symbiosis with nitrogen-fixing Rhizobium spp. Among flavonoids, many beneficial effects for human health, ranging from antioxidant activities to the inhibition of carcinogenesis, are attributed to proanthocyanidins (PAs). This study compared the neuroprotective properties of leaf extracts from PA-rich Lotus corniculatus (Lc), PA-depleted Lotus tenuis (Lt), and Lc × Lt interspecific hybrid (Lh2) with intermediate PA levels. Acetone-soluble and -insoluble fractions from Lc and Lh2 contained flavan-3-ols and PA oligomers, while Lt lacked these compounds. Neuroprotective assays in SH-SY5Y cells and Caenorhabditis elegans revealed that Lc and, although to a lesser extent, Lh2 extracts enhanced cell viability and reduced motoneuron degeneration, whereas Lt extracts exhibited cytotoxicity and did not induce motoneuron viability rescue in C. elegans. Further analysis confirmed that pure flavan-3-ols, which represent the main components of the acetone-soluble fraction in Lc and Lh2, and cyanidin, which derives from the hydrolysis of their insoluble fractions, significantly promoted neuronal survival, while the flavonol quercetin showed no protective effects. These findings highlight the neuroprotective potential of PA-rich Lotus spp. and suggest their application as novel sources of health-promoting phytochemicals.